Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data. (Q33989357)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

C. Daniel Mullins

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Ebere Onukwugha

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Naimish Pandya

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Nader Hanna

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

0 references

publication date

10 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Journal of the American Geriatrics Society

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

59

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1717-1723

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Adjuvant chemotherapy for stages II, III and IV of colon cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Aging and cancer in America. Demographic and epidemiologic perspectives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Multimorbidity and survival in older persons with colorectal cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Hospital factors and racial disparities in mortality after surgery for breast and colon cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Completion of therapy by Medicare patients with stage III colon cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03501.X

21 January 2018

Identifiers

10.1111/J.1532-5415.2011.03501.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21831168%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33989357&oldid=1973168436"